Biocare Medical

Biocare Medical is a private, revenue-generating company specializing in integrated pathology solutions, including antibodies, detection systems, and automated staining instruments. Founded in 1996 and headquartered in Pacheco, USA, the company serves clinical and research laboratories worldwide with a focus on cancer diagnostics. Its strategy revolves around providing a complete, optimized platform to ensure consistent and efficient IHC, ISH, and FISH staining, which has led to significant market penetration, including placements in top cancer centers. In 2024, the company entered into an agreement to be acquired by Agilent Technologies.

Integrated platform of primary antibodies, detection reagents, and automated staining instruments optimized for IHC, ISH, and FISH workflows, designed for consistency and digital pathology readiness.

Biocare competes in a crowded market with major players like Roche (Ventana), Danaher (Leica Biosystems), and Thermo Fisher Scientific, as well as numerous specialty antibody companies. Its differentiation lies in its integrated 'platform' approach, optimizing reagents and instruments together, and its focus on high-quality antibodies and multiplexing solutions.